EXHIBIT 32.2
Published on March 16, 2009
Exhibit
32.2
CERTIFICATION
OF
CHIEF
FINANCIAL OFFICER
PURSUANT
TO
18 U.S.C.
SECTION 1350
SECTION
1350 CERTIFICATION*
In
connection with the Annual Report of Rexahn Pharmaceuticals, Inc. (the
“Company”) on Form 10-K for the fiscal year ended December 31, 2008 as filed
with the Securities and Exchange Commission on the date hereof (the “Report”),
I, Tae Heum Jeong, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge:
|
(1)
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the
Company.
|
|
Dated:
March 16, 2009
|
By:
|
/s/
Tae Heum Jeong
|
|
|
Tae
Heum Jeong,
|
|||
|
Chief
Financial Officer
|
|
*
|
This
Certification is being furnished as required by Rule 13a-14(b) under
the Securities Exchange Act of 1934 (the “Exchange Act”) and
Section 1350 of Chapter 63 of Title 18 of the United States
Code, and shall not be deemed “filed” for purposes of Section 18 of the
Exchange Act or otherwise subject to the liability of that section. This
Certification shall not be deemed to be incorporated by reference into any
filing under the Securities Act of 1933 or the Exchange Act, except as
otherwise stated in such filing.
|
A signed
original of this written statement required by 18 U.S.C. § 1350 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.